Serum immune checkpoint profiling identifies soluble CD40 as a biomarker for pancreatic cancer

Pancreatic ductal adenocarcinoma (PDAC) responds poorly to systemic treatment, including new immunotherapeutic approaches. Biomarkers are urgently needed for early disease detection, patient stratification for treatment, and response prediction. The role of soluble CD40 (sCD40) is unknown in PDAC. I...

Descripción completa

Detalles Bibliográficos
Autores principales: Digomann, David, Heiduk, Max, Reiche, Charlotte, Glück, Jessica, Kahlert, Christoph, Mirtschink, Peter, Klimova, Anna, Bösch, Florian, Tonn, Torsten, Gaedcke, Jochen, Ghadimi, Michael, Weitz, Jürgen, Seifert, Lena, Seifert, Adrian M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10576756/
https://www.ncbi.nlm.nih.gov/pubmed/37838778
http://dx.doi.org/10.1038/s41698-023-00459-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10576756/
https://www.ncbi.nlm.nih.gov/pubmed/37838778
http://dx.doi.org/10.1038/s41698-023-00459-9

Ejemplares similares